PFF Summit 2017 Patient Sessions
Thursday > Session
Patients and Caregivers: Intro to the PFF, Your Call to Action, and Understanding the Basics of Research
Kevin Flaherty, MD, MS: Introduction of the PFF and the Care Center Network VIEW SLIDES | |
Hal Collard, MD, John Morthanos, and David McNinch: Research 101: Understanding the process, terminology, definitions, and how a drug is brought to market VIEW SLIDES | |
Kate Gates, Anne Dimmock, Lisa Boyd, Dot Delarosa, Barbara Murphy: Need Meets Action Part I: Overview of volunteering at the PFF | |
Amanda Miller: Need Meets Action Part II: Overview of effective fundraising VIEW SLIDES |
Friday > Sessions
Keynote Address
Jim Kiley, : National Heart, Lung, and Blood Institute (NHLBI) support for personalized therapy in lung disease VIEW SLIDES |
Plenary Session I: Promise of Genetics and Personalized Medicine in PF
LEADERS: Bill Schmidt and Greg Cosgrove, MD
Jeff Trent: State-of-the-art approaches to genetic discovery in complex disease VIEW SLIDES | |
Jim Loyd, MD: Current status of clinical genetic testing in ILD VIEW SLIDES | |
Janet Talbert MS, CGC: A genetic counselor's perspective: Impact of genetic information for patients and families VIEW SLIDES |
Kidbilly Music, Presented by Genentech
Kidbilly Perspectives from All: Songwriting for team-building, networking, and emotional healing |
Understanding ILD and IPF
LEADERS: Amanda Miller
Kristin Highland, MD: Part I: Overview of ILD, IPF, and connective tissue disease SLIDES AND WEBINAR ARE UNAVAILABLE AT THIS TIME
Mary Beth Scholand, MD: Part II: Understanding your test results: HRCT, 6MWT, PFTs, and oximetry SLIDES AND WEBINAR ARE UNAVAILABLE AT THIS TIME
Quality of Life: Next Steps
LEADER: Amanda Miller
Josh Mooney, MD, MS: Part I: Evaluation for lung transplantation VIEW SLIDES | |
Linda Manning, MD: Part II: Using mindfulness for stress management in chronic disease VIEW SLIDES | |
Wendi Mason, MSN: Part III: Treatment of cough VIEW SLIDES |
Call to Action Part I
LEADER: Kate Gates
Oxygen Therapy, Pulmonary Rehabilitation, and Symptom Management
LEADER: Heather Kundert
Susan Jacobs, RN, MS: Part I: Living with oxygen therapy and PF; Overview of various types of POCs, compressed gas units, trans-fill systems, and backpacks; How can I be active and travel with O2 (MedJet and other emergency travel services)? SLIDES AND WEBINAR ARE FORTHCOMING | |
Trina Limberg, BS, RRT: Part II: Pulmonary rehab: What is it and how can it help me? SLIDES AND WEBINAR ARE UNAVAILABLE AT THIS TIME | |
Wendi Mason, MSN: Part III: Symptom management: , dyspnea, and fatigue SLIDES AND WEBINAR ARE UNAVAILABLE AT THIS TIME |
What's in the Pipeline? Current Clinical Trials, Potential Therapies, and How the Process Works
LEADER: Greg Cosgrove, MD
Bill Bradford, MD, : Part I: Understanding how clinical trials work and the therapeutic process to bring a drug to market VIEW SLIDES | |
Greg Cosgrove, MD: Part II: Current clinical drug trials in the pipeline for IPF and PF, and an overview of potential therapies moving forward SLIDES AND WEBINAR ARE UNAVAILABLE AT THIS TIME |
Call to Action Part II: How to Host a Fundraising Event
LEADER: Seth Klein
Amy Kozyra: How to host a fundraising event VIEW SLIDES |
Saturday > Sessions
Keynote Address
Gordon R. Bernard, MD: Re-thinking clinical trials in PF | VIEW SLIDES |
Plenary Session and Panel Discussion: Maximizing the Impact of Available Therapies in IPF
LEADERS: Lisa Lancaster, MD
Kevin Flaherty, MD, MS: PFF Care Center Networks and PFF Patient Registry| VIEW SLIDES | |
Jason Martin, MD: Improving care for PF patients and adherence to treatment plans: A physician family member's perspective | VIEW SLIDES | |
PANEL: Carolyn Adams-Duda, Kevin Flaherty, Jason Martin, Gregory Cosgrove, Maryluz Fuentes |
Basics of Genetics and What We Know About Stem Cell Therapy
LEADER: Heather Kundert
Jim Loyd, MD: Part I: Genetics 101 in IPF VIEW SLIDES | |
Sonye Danoff, MD: Part II: Stem cell therapies and ; What is stem cell therapy and what is it approved for? Stem cell centers in the community VIEW SLIDES | |
Marilyn Glassberg, MD: Part III: Clinical trials with stem cells for ILD VIEW SLIDES | |
Q&A Panel |
Diagnosis and Treatment of Comorbidities and Approved Therapies for IPF
LEADER: Mary Kiener
Joyce Lee, MD: Part I: Overview of pirfenidone and nintedanib VIEW SLIDES | |
Wendi Mason, MSN: Part II: Adherence to treatment plans: Safety and management of side effects with pirfenidone and nintedanib VIEW SLIDES | |
Anne Turner, RN, BSN: Part III: How to qualify for reduced payment plans VIEW SLIDES |
Roundtable Discussions
LEADER: Kate Gates
John Mulder: Caregiver burnout VIEW SLIDES | |
David Lederer, MD, and Michele Peters: How to prepare for an effective clinical visit with your doctor | |
Jim Jackson, : Depression and anxiety in chronic disease VIEW SLIDES | |
Kathleen O. Lindell, , RN: Palliative and hospice care VIEW SLIDES | |
Kate Gates: How to participate in legislative advocacy VIEW SLIDES |